Abstract:
Objective To investigate the prognostic and potential therapeutic value of cuproptosis-related long non-coding RNA(lncRNA)in hepatocellular carcinoma(HCC)patients.
Methods The transcriptome data and clinical data of hepatocellular carcinoma were collected from the TCGA database. The genes related to cuproptosis that were differentially expressed in cancer tissues and normal liver tissues were screened, and Gene Ontology(GO)enrichment analysis and Kyoto Gene and Genome Database(KEGG)pathway analysis were performed. Cuproptosis-related lncRNA associated with the prognosis of HCC were screened, patients' data were grouped, and overall survival rates were compared. The prognostic risk model was established by using LASSO Cox regression analysis. The nomogram was also built to predict overall survival in HCC patients.
Results A prognostic model consisting of 5 cuproptosis-related lncRNA was established, including RPS6KA6, SNRPEP2, PRELID2, GOT2, and RTL8A. The risk score and TNM stage diagram show the model has good predictive ability. This prognostic model is related to tumor immune escape and the expression of related genes under immune function.
Conclusions The cuproptosis-related lncRNA prognostic model successfully constructed in this study has certain accuracy and reliability in predicting the survival prognosis of HCC patients, providing clues for the interaction between Cuproptosis and HCC immunity. The treatment with Cuproptosis as the core is expected to provide new ideas for treating HCC.